We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BBIXF market cap is 350.38k. The company's latest EPS is ILS -0.0331 and P/E is 0.00.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.45M | -20.91M | -19.44M | -64.74M | -37.05M |
| Net Income | -18.74M | -22.24M | -22.02M | -90.08M | -38.7M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
| Total Assets | 10.16M | 6.99M | 51.44M | 104.32M | 74.61M |
| Total Liabilities | 13.34M | 20.71M | 20.75M | 19.89M | 18.22M |
| Total Equity | -3.18M | -13.72M | 30.68M | 84.43M | 56.39M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
| Operating | -13.43M | -13.11M | -15.75M | -39.84M | -28.82M |
| Investing | -341k | -187k | -254k | -6.18M | -6.29M |
| Financing | 19.56M | 4.92M | 31.92M | 113.42M | 2.14M |
| Market Cap | 350.38k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 1.17B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 478 |
| 52 Week Change | -25.00% |
| 52 Week High | 0.055 |
| 52 Week Low | 0.0003 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Bonus Biogroup Ltd (CE) |
| Address |
park matam 8a haifa, haifa 31905 |
| Website | https://www.bonusbiogroup.com |
| Industry | pipelines, nec (4619) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
